Total Payments
$1,455
2024 Payments
$44.81
Companies
15
Transactions
137
Medicare Patients
3,047
Medicare Billing
$344,298
Payment Breakdown by Category
Food & Beverage$1,452 (99.8%)
Education$2.50 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,452 | 136 | 99.8% |
| Education | $2.50 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $895.52 | 109 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $188.32 | 5 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $90.02 | 7 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $53.65 | 3 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $34.49 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $33.37 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $33.33 | 2 | $0 (2019) |
| ABBVIE INC. | $28.41 | 1 | $0 (2024) |
| Gilead Sciences Inc | $24.75 | 1 | $0 (2017) |
| Genentech USA, Inc. | $17.62 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.81 | 2 | ABBVIE INC. ($28.41) |
| 2021 | $188.04 | 19 | GlaxoSmithKline, LLC. ($132.00) |
| 2020 | $231.05 | 19 | Boehringer Ingelheim Pharmaceuticals, Inc. ($120.30) |
| 2019 | $521.41 | 49 | GlaxoSmithKline, LLC. ($298.96) |
| 2018 | $237.50 | 28 | GlaxoSmithKline, LLC. ($194.55) |
| 2017 | $231.74 | 20 | GlaxoSmithKline, LLC. ($142.86) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VACCINES | ||||||
| 11/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.33 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2021 | United Therapeutics Corporation | ORENITRAM (Drug) | Education | In-kind items and services | $2.50 | General |
| Category: PAH | ||||||
| 10/26/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2021 | Advanced Respiratory, Inc | Life 2000 Ventilation System (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Airway Clearance Device | ||||||
| 10/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: RESPIRATORY | ||||||
| 07/21/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: RESPIRATORY | ||||||
| 07/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: RESPIRATORY | ||||||
| 07/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: RESPIRATORY | ||||||
| 06/23/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: RESPIRATORY | ||||||
| 05/25/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: RESPIRATORY | ||||||
| 03/23/2021 | Philips Electronics North America Corporation | (8876) Vest Therapy Und (Device) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Medical Device | ||||||
| 03/04/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: RESPIRATORY | ||||||
| 02/10/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: RESPIRATORY | ||||||
| 01/20/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: RESPIRATORY | ||||||
| 12/14/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 135 | 684 | $137,036 | $44,707 |
| 2022 | 11 | 543 | 1,100 | $210,068 | $64,389 |
| 2021 | 15 | 1,188 | 1,769 | $366,529 | $119,577 |
| 2020 | 19 | 1,181 | 1,682 | $413,255 | $115,624 |
Total Patients
3,047
Total Services
5,235
Medicare Billing
$344,298
Procedure Codes
53
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 492 | $89,544 | $29,401 | 32.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 115 | $30,130 | $10,403 | 34.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 24 | $12,168 | $3,121 | 25.6% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 29 | 53 | $5,194 | $1,783 | 34.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 523 | $95,186 | $28,253 | 29.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 138 | 166 | $44,820 | $14,062 | 31.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 71 | $18,602 | $5,590 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 24 | $12,168 | $3,511 | 28.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 52 | 53 | $9,699 | $2,996 | 30.9% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 49 | 54 | $5,886 | $2,413 | 41.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 18 | $6,570 | $2,170 | 33.0% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 63 | 70 | $7,000 | $2,142 | 30.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 39 | 44 | $6,160 | $2,076 | 33.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 28 | $2,744 | $815.69 | 29.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 17 | 17 | $527.00 | $154.26 | 29.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 17 | 17 | $391.00 | $114.05 | 29.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 15 | 15 | $315.00 | $92.03 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 227 | 315 | $85,050 | $29,266 | 34.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 104 | 411 | $74,802 | $22,670 | 30.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 61 | 190 | $50,738 | $14,852 | 29.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 132 | 138 | $25,254 | $8,943 | 35.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 47 | 50 | $25,350 | $7,406 | 29.2% |
| 94726 | Determination of lung volumes using plethysmography | Office | 2021 | 131 | 140 | $15,260 | $6,275 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 49 | 49 | $19,257 | $6,023 | 31.3% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 99 | 112 | $15,680 | $5,520 | 35.2% |
About Dr. Laura Gilbey, M.D
Dr. Laura Gilbey, M.D is a Critical Care Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1932102316.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Gilbey, M.D has received a total of $1,455 in payments from pharmaceutical and medical device companies, with $44.81 received in 2024. These payments were reported across 137 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,452).
As a Medicare-enrolled provider, Gilbey has provided services to 3,047 Medicare beneficiaries, totaling 5,235 services with total Medicare billing of $344,298. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Austin, TX
- Active Since 05/31/2005
- Last Updated 10/24/2016
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1932102316
Products in Payments
- TRELEGY ELLIPTA (Drug) $439.19
- ANORO (Drug) $263.77
- OFEV (Drug) $172.27
- NUCALA (Biological) $68.91
- ANORO ELLIPTA (Drug) $68.43
- UPTRAVI (Drug) $53.65
- LONHALA MAGNAIR (Drug) $49.38
- DUPIXENT (Biological) $34.49
- BREO (Drug) $33.31
- BOTOX (Biological) $28.41
- SYMBICORT (Drug) $21.23
- UTIBRON (Drug) $20.88
- BROVANA (Drug) $19.76
- inCourage (Device) $18.55
- Esbriet (Biological) $17.62
- BEXSERO (Biological) $16.40
- SPIRIVA RESPIMAT (Drug) $16.05
- Yupelri (Drug) $14.94
- (8876) Vest Therapy Und (Device) $14.82
- SMARTVEST (Device) $14.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Austin
Shenil Shah, M.d, M.D
Critical Care Medicine — Payments: $5,658
Critical Care Medicine $5,658
Mr. Christopher Brown, M.d, M.D
Critical Care Medicine — Payments: $3,132
Critical Care Medicine $3,132
Robert Morrison, M.d, M.D
Critical Care Medicine — Payments: $2,860
Critical Care Medicine $2,860
Dr. Thaw Sint, Md, MD
Critical Care Medicine — Payments: $2,422
Critical Care Medicine $2,422
Dr. Anna Dvorak, Md, MD
Critical Care Medicine — Payments: $2,311
Critical Care Medicine $2,311
Andrea Fekete, M.d, M.D
Critical Care Medicine — Payments: $2,237
Critical Care Medicine $2,237